About Understanding Cancer Immunotherapy Research
Understanding Cancer Immunotherapy Research (UCIR) is a new resource dedicated to patients undergoing or interested in cancer immunotherapy.
The site offers easy-to-understand explanations and visuals on the new therapies. Patients can explore a database of the latest immunotherapy drugs approved by the FDA and EMA. Go to UCIR.org to learn more about the immune system and how it can be harvested to fight cancer. UCIR is part of the Fritsch Foundation, a 501c3 organization, EIN 47-3974944.